Evidence map›Paper›PMID 24292688›Full record

ReviewHeart failure reviews2014

Novel approaches to the post-myocardial infarction/heart failure neural remodeling.

Emilia D'Elia, Alessia Pascale, Nicoletta Marchesi, Paolo Ferrero, Michele Senni, Stefano Govoni, Edoardo Gronda, Emilio Vanoli

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02243514 (Intravascular Ultrasound Evaluation of the Renal Nerves Remodeling in Different Diseases), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02243514 unknown statusnot on this map

Intravascular Ultrasound Evaluation of the Renal Nerves Remodeling in Different Diseases

TypeobservationalSponsorThe Second Affiliated Hospital of Chongqing Medical UniversityRan2014 to 2015Enrolled60ConditionsHypertension, Heart Failure
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Emilia D'EliaCardiovascular Department, Azienda Ospedaliera Papa Giovanni XXIII, Piazza OMS 1, 24120, Bergamo, Italy, edelia@hpg23.it.
Alessia Pascale
Nicoletta Marchesi
Paolo Ferrero
Michele Senni
Stefano Govoni
Edoardo Gronda
Emilio Vanoli
Ospedale Papa Giovanni XXIII · ITUniversity of Pavia · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITMultiMedica · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The review aims to discuss the role of nerve growth factor (NGF) as a potential novel biomarker in post-myocardial infarction (MI) and in heart failure (HF), with a specific focus on neural remodeling and sprouting processes occurring after tissue damage. Many experimental data show that MI induces nerve sprouting, leading to increased sympathetic outflow and higher risk of ventricular arrhythmias and sudden cardiac death. In this framework, cardiac and circulating NGF might be an indicator of the innervation process and neural remodeling: it dramatically increases after MI, while it declines along with advanced HF and ventricular dysfunction. The bimodal behavior of NGF in acute and chronic settings leads to the speculation that NGF modulation may be a pharmacological target for intervention in different stages of the ischemic heart disease. Specifically, a fascinating possibility is to support or to inhibit NGF receptors, in order to prevent negative cardiac remodeling after MI and consequent ventricular dysfunction.

Indexed as

HeartHeart FailureHumansMyocardial InfarctionNerve Growth FactorSympathetic Nervous SystemNerve Growth Factor

Identifiers

PMID24292688
OpenAlexW2040522287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.